GlaxoSmithKline Net Income TTM:
6.620B for March 31, 2013GlaxoSmithKline Historical Net Income TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 6.620B |
| Dec. 31, 2012 | 7.247B |
| Sept. 30, 2012 | 7.785B |
| June 30, 2012 | 8.110B |
| March 31, 2012 | 7.932B |
| Dec. 31, 2011 | 8.286B |
| Sept. 30, 2011 | 5.287B |
| June 30, 2011 | 5.176B |
| March 31, 2011 | 2.950B |
| Dec. 31, 2010 | 2.528B |
| Sept. 30, 2010 | 6.218B |
| June 30, 2010 | 6.315B |
| March 31, 2010 | 9.150B |
| Dec. 31, 2009 | 8.742B |
| Sept. 30, 2009 | 7.542B |
| June 30, 2009 | 7.260B |
| March 31, 2009 | 7.447B |
| Dec. 31, 2008 | 8.442B |
| Sept. 30, 2008 | 9.146B |
| June 30, 2008 | 9.967B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
About Net Income (TTM)
GSK Net Income TTM Benchmarks
| Companies | |
|---|---|
| Merck | 6.022B |
| AstraZeneca | 5.668B |
| Eli Lilly and Company | 4.626B |
GSK Net Income TTM Rankings
| Overall |
99th percentile 48 of 8002 |
| Sector |
99th percentile 4 of 684 in Healthcare |
| Industry |
92nd percentile 4 of 54 in Drug Manufacturers - Major |
GSK Net Income TTM Range, Past 5 Years
| Minimum | 2.528B | Dec 2010 |
| Maximum | 9.967B | Jun 2008 |
| Average | 7.107B |
